Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

And, above all, we stay focused on the evidence. The clinical picture for vaccine policy in the United States suddenly seems more confusing than at any point in the past year. On Monday, a federal ...

One example of this potential comes from studies on glioblastoma, an aggressive brain tumor with few effective treatments.

In today's Pharmaceutical Executive Daily, a federal judge blocks RFK Jr.'s reconstituted vaccine advisory committee and ...

Just over half of the eligible population had the Covid-19 booster, with experts keen to see it given alongside the annual flu vaccine.

The surge in vaccine litigation is not simply a post-pandemic, temporary issue. It is a deeper erosion of the legal ...

Appellate court confirmed that employee is ineligible for employment insurance after refusing COVID-19 vaccination on ...

Older adults experience inconsistent outpatient COVID-19 antiviral prescribing despite high risk for severe outcomes and hospitalization.

Local health experts are sounding the alarm amid decreased vaccination rates for preventable infectious diseases and a pair ...

CDC data show SARS-CoV-2 and RSV continue to impact younger children and older adults, with significant hospitalization and mortality rates across the US.

"As these viruses continue to evolve, public health officials watch carefully to see whether new strains will be more easily ...

Paul Conyngham, an Australian tech entrepreneur, has claimed he used both OpenAI’s ChatGPT and Google DeepMind’s AlphaFold to ...